Press release
Elevated Prevalence Of Heart Diseases As A Catalyst For Biomarkers Market Expansion : A Key Factor Shaping the Future of the Biomarkers Market in 2025
What combination of drivers is leading to accelerated growth in the biomarkers market?The escalating trend in cardiac conditions can be linked to the growth of the biomarkers market in the projected timeframe. The utilisation of biomarkers in cardiac patients has witnessed significant acceleration in the recent past. Presently, natriuretic peptides are the most commonly utilized biomarkers for diagnosing heart failure cases. High sensitivity C-reactive protein and other circulating biomarkers are also routinely used in the diagnosis of cardiac failure. Cardiac disease is a major cause of mortality in diverse racial and ethnic groups in the United States. Hence, the surge in cardiac diseases will inevitably catalyze the demand for biomarkers. For instance, in August 2022, a study by the American College of Cardiology, a US-based charitable medical association, predicted that all four cardiovascular risk factors in the United States are likely to witness an upward trajectory between 2025 and 2060. The highest projected surge is expected in diabetes with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). They also highlighted expected surges in the rate of stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). The rising incidence of cardiac diseases and deaths will drive the biomarkers market's growth.
Get Your Biomarkers Market Report Here:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
What is the projected compound annual growth rate (CAGR) of the biomarkers market from 2025 to 2034, and what factors influence it?
Over the past few years, the size of the biomarkers market has expanded rapidly. It is projected to grow from a sizable $68.77 billion in 2024 to an even larger $78.14 billion in 2025, at a compounded annual growth rate (CAGR) of 13.6%. This significant increase in the historical timeline can be traced back to the improvements in genomics and proteomics technologies, a rising occurrence of chronic illnesses, a growing focus on personalized medicine, an upsurge in the hunt for companion diagnostics, and a widening of applications within the realm of drug development.
Over the upcoming years, the biomarkers market is forecasted to witness tremendous expansion. The market is predicted to touch a mark of $135.14 billion in 2029, with a compound annual growth rate (CAGR) of 14.7%. This growth during the prediction period is primarily influenced by the increasing emphasis on early detection and prevention of diseases, the widespread use of biomarkers in oncology and immunotherapy, escalated investments in precision medicine initiatives, the rising prominence of liquid biopsy as a non-invasive method for biomarker detection, and the growing inclination towards using biomarkers in drug discovery and development. Key trends pertaining to the prediction period encompass the development of multi-biomarker panels, emergence of exosome-based biomarkers, widespread adoption of point-of-care biomarker testing, incorporation of real-world data in biomarker research, and exploration of microbiome-based biomarkers.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp
How are the latest trends influencing the growth of the biomarkers market?
Key businesses within the biomarker sector are directing their efforts towards the advancement of original and inventive solutions, such as a groundbreaking biological marker. This is done through synergistic research, technology amalgamation, and substantial clinical validation. A cutting-edge biological marker serves as a recently identified sign of biological processes, aiding in the detection and tracking of diseases. Such markers could be molecular, gene-based, or a characteristic of a cell, with significant potential for bespoke medicine. In September 2024, for example, a first-of-its-kind biomarker was unveiled by Genialis, an American firm specializing in computational precision medicine. This pioneering biomarker provides improved predictions of patient responses to KRAS inhibitors, allowing for personalized treatment plans and better patient outcomes. With its wide-ranging application in diverse cancer types, it enhances efficient drug development and refines the selection process for targeted therapies.
What are the major segments of the biomarkers market and their role in driving growth?
The biomarkers market covered in this report is segmented -
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485
Which regions are key players in the growth of the biomarkers market?
North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the biomarkers market?
Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp
What Is Covered In The Biomarkers Global Market Report?
•Market Size Forecast: Examine the biomarkers market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the biomarkers market for a structured understanding.
•Key Players Overview: Analyze major players in the biomarkers market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the biomarkers market.
•Segment Contributions: Evaluate how different segments drive overall growth in the biomarkers market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the biomarkers market.
•Industry Challenges: Identify potential risks and obstacles affecting the biomarkers market.
•Competitive Landscape: Review strategic developments in the biomarkers market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevated Prevalence Of Heart Diseases As A Catalyst For Biomarkers Market Expansion : A Key Factor Shaping the Future of the Biomarkers Market in 2025 here
News-ID: 3880531 • Views: …
More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…

Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…

Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…

Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…